Navigation Links
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Date:4/30/2008

SEATTLE, April 30 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following investor conferences in May.

Deutsche Bank 33rd Annual Health Care Conference

InterContinental Boston

Tuesday, May 6, 2008

8:50 a.m. ET

Bank of America Health Care Conference

Four Seasons Hotel, Las Vegas

Tuesday, May 13, 2008

11:00 a.m. ET

Rodman & Renshaw 5th Annual Global Health Care Conference

Le Meridien Beach Plaza Hotel, Monte Carlo

Monday, May 19, 2008

9:30 a.m. ET

The presentations will be audio webcast live and available for replay from Dendreon's website, http://www.dendreon.com.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Dendreon Announces Closing of Registered Direct Offering
2. Dendreon Announces $47 Million Registered Direct Offering
3. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
4. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
5. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
6. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
9. Dendreon Reports Third Quarter 2007 Financial Results
10. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
11. Dendreon Secures $130 Million Committed Equity Financing Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... A new clinical study presented to the Amer...three-dimensional (3-D) automated ultrasound folli... an in vitro fertilization (IVF) cycle is effectiv...rement of the follicles. , ...ced Fertility Center of Chicago has just completed...
(Date:11/30/2009)...BUS, Ohio, Nov. 30 The Ohio Capita...e nation,s first minority business early-stage cap...December 3, is called "Transforming the Landscape ...Stage Capital Summit." It will feature several spe...ess leaders and local minority entrepreneurs. ,...
(Date:11/30/2009)...ILLE, Md., Nov. 30 Novav... company, announced today that the company will be...nce 2009 on December 2, 2009 at 12:30 pm local tim...provide an overview of the company,s business stra...ng milestones. A link to the live audio only pres...
(Date:11/30/2009)...ILLE, Md., Nov. 30 Novav...ompleted enrollment in the Phase II clinical study...commended strains) VLP vaccine candidate in health... This randomized, double-blind, active-controlled ...munogenicity of two different doses (15 mcg and 60...
Breaking Biology Technology:Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4
...al, Inc., the global leader in devices for clot re... that it has completed a $15 million round of fina...al firm New Enterprise Associates, Inc. (NEA) and ...s. , , "The positive developments at Concentric o...o participate in this round of financing very attr...
...sdaq: FOLD ) today announced the election of Sol...Barer currently serves as Chairman and Chief Execu...ry veteran, Dr. Barer brings over 20 years of mana...d respected leader who has helped transform Celgen...ical companies. , , John F. Crowley, President an...
...erence on Health Informatics (HEALTHINF 2009) will..."Open Source in European Health Care: The Tim...Portugal (PRWEB) January 8, 2009 -- OpenClinica wi...ing International Conference on Health Informatics...rtugal. The workshop, titled "Open Source in ...
Other Biology Technology:Concentric Medical Closes on $15 Million Financing 2Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors 2OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal 2
(Date:12/1/2009)... been awarded a U.S. Air Force Center of Excellenc...nd adaptive materials, and to develop tools to opt...arfighter. , The $10.5 million Center, known as...ures and Improved Cognition (BIONIC) center, is be...professors in Georgia Tech,s School of Materials S...
(Date:12/1/2009)... -- iQor, a global provider of business process ou... InfoWorld 100 Awards Top 100 IT project of 2009... was the first submission for iQor. ,, "We are ...st of companies," said Vikas Kapoor, president and...e way we do business, allowing us to work faster, ...
(Date:12/1/2009)...he radio anymore. They,re used in everything from ...rolina State University is revolutionizing the fie...nnas that open the door to a host of new uses in f...yment. , Modern antennas are made from copper or...r they can be bent and how often before they bre...
Breaking Biology News(10 mins):Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Shape shifters: Researchers create new breed of antennas 2Travel Nurse Across America Expands Into New Offices 51338 1Travel Nurse Across America Expands Into New Offices 51338 2Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug 9 51336 1Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug 9 51336 2Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug 9 51336 3New research to reduce drug side effects 51334 1New research to reduce drug side effects 51334 2
...harmaceutical Research & Development (J&JP...w molecular mechanism that may underlie neuropathi...e of chronic neuropathic pain, and the preclinical...apies shown in this research, together present an ...at the severe pain associated with such common con...
... strains of influenza showed genetic differences f...d-virus flu shot was found to be effective in prev...uated-virus nasal spray vaccine also prevented ill...e determined by laboratory confirmation of flu inf...Earlier studies had suggested that the nasal spray...
...lege of Medicine of Yeshiva University have receiv...titute to study tumor "microenvironments" --where ...d chemicals in ways that all too often encourage c...he process known as metastasis. , With the new NC...nd structural biology at Einstein and the principa...
Other Biology News: New mechanism underlying pain found 2Flu shot effective against drifted influenza, nasal spray vaccine less so 2Flu shot effective against drifted influenza, nasal spray vaccine less so 3World's smallest cancer detection device 2
...n Ribonuclease Inhibitors have broad spectrum RNas...of eukaryotic RNases of the neutral type (1). The ...ovalently binding to RNases in a 1:1 ratio. The Ki...bitor to RNase (e.g., RNase A) is approximately 10...
HEPA Filtered Single Chamber Water Jacketed Incubator, CO2/O2 IR, 115V, 50/60 Hz from Thermo Scientific
CnAOSMC (Cn354-05) from European Collection of Cell Cultures (ECACC)
...d cell lines in combination with the corresponding...rameters. Nucleofector Kits are only functional in...rent cell lines can be transfected with this kit. ... given in brackets in percent (Efficiency [%] / vi...
Biology Products: